Twist Bioscience Is Maintained at Outperform by Leerink Partners
Ratings actions from Benzinga: GMT) Twist Bioscience Price Target Raised to $190.00/Share From $160.00 by Leerink PartnersRatings actions from Benzinga
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Twist Bioscience price target raised to $160 by Leerink
Leerink Partners raised its price target for Twist Bioscience to $160.00 per share from $120.00, per Benzinga’s ratings-action report.